The Natural Flavone Acacetin Confers Cardiomyocyte Protection Against Hypoxia/Reoxygenation Injury Via AMPK-Mediated Activation of Nrf2 Signaling Pathway
Overview
Authors
Affiliations
The present study investigates the potential signal pathway of acacetin in cardioprotection against ischemia/reperfusion injury using an hypoxia/reoxygenation model in primary cultured neonatal rat cardiomyocytes and H9C2 cardiomyoblasts. It was found that acacetin (0.3-3 μM) significantly decreased the apoptosis and reactive oxygen species production induced by hypoxia/reoxygenation injury in cardiomyocytes and H9C2 cardiomyoblasts via reducing the pro-apoptotic proteins Bax and cleaved-caspase-3 and increasing the anti-apoptotic protein Bcl-2. In addition, acacetin not only suppressed the release of pro-inflammatory cytokines TLR-4 and IL-6 induced by hypoxia/reoxygenation injury, but also increased the secretion of anti-inflammatory cytokine IL-10. Moreover, acacetin increased Nrf2 and HO-1 in a concentration-dependent manner, and rescued SOD1 and SOD2 reduction induced by hypoxia/reoxygenation insult. These beneficial effects of acacetin disappeared in cells with silenced Nrf2, suggesting that Nrf2 activation participates in the cardioprotective effect of acacetin against hypoxia/reoxygenation insult. However, acacetin-induced Nrf2 activation was not observed in cells with silenced AMPK and in ventricular tissues of rat hearts treated with the AMPK inhibitor Compound C and subjected to ischemia/reperfusion injury. Our results demonstrate for the first time that AMPK-mediated Nrf2 activation is involved in the cardiomyocytes protection of acacetin against hypoxia/reoxygenation injury by activating a series of intracellular signals involved in anti-oxidation, anti-inflammation, and anti-apoptosis.
Lu Q, Yao X, Zheng H, Ou J, You J, Zhang Q Heliyon. 2024; 10(20):e38584.
PMID: 39506934 PMC: 11538732. DOI: 10.1016/j.heliyon.2024.e38584.
Acacetin protects against acute lung injury by upregulating SIRT1/ NF-κB pathway.
Gu L, Yin Y, Liu M, Yu L Heliyon. 2024; 10(17):e37083.
PMID: 39296097 PMC: 11409107. DOI: 10.1016/j.heliyon.2024.e37083.
Chen L, Du Y, Hu Y, Li X, Chen Y, Cheng Y Transl Psychiatry. 2024; 14(1):267.
PMID: 38951484 PMC: 11217384. DOI: 10.1038/s41398-024-02984-y.
Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation.
Bu J, Mahan Y, Zhang S, Wu X, Zhang X, Zhou L Front Pharmacol. 2024; 15:1286546.
PMID: 38389927 PMC: 10883387. DOI: 10.3389/fphar.2024.1286546.
Nrf2-mediated therapeutic effects of dietary flavones in different diseases.
Huang W, Zhong Y, Gao B, Zheng B, Liu Y Front Pharmacol. 2023; 14:1240433.
PMID: 37767395 PMC: 10520786. DOI: 10.3389/fphar.2023.1240433.